Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 26, 1970 - Issue 4
Submit an article Journal homepage
26
Views
88
CrossRef citations to date
0
Altmetric
Original Article

Comparison of Progressive Antithrombin Activity and the Concentrations of Three Thrombin Inhibitors in Human Plasma

U. Abildgaard Haematological Research Laboratory, Dept. IX, and the Blood Bank, Ullevål Hospital, University Clinic, Oslo, Norway; Institute for Thrombosis Research, Rikshospitalet, University Clinic, Oslo, Norway
,
M. K. Fagerhol Haematological Research Laboratory, Dept. IX, and the Blood Bank, Ullevål Hospital, University Clinic, Oslo, Norway; Institute for Thrombosis Research, Rikshospitalet, University Clinic, Oslo, Norway
&
O. Egeberg Haematological Research Laboratory, Dept. IX, and the Blood Bank, Ullevål Hospital, University Clinic, Oslo, Norway; Institute for Thrombosis Research, Rikshospitalet, University Clinic, Oslo, Norway
Pages 349-354 | Received 09 Jun 1970, Accepted 17 Sep 1970, Published online: 08 Jul 2009

Citations (88)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lilian Tengborn, Birgitta Frohm, L. E. Nilsson & Inga Marie Nilsson. (1981) Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency. Scandinavian Journal of Clinical and Laboratory Investigation 41:5, pages 469-477.
Read now
Ulf Larsson-cohn, Magne K. Fagerhol & Ulrich Abildgaard. (1972) Concentration of Antithrombin III During Combined and Progestogen-Only Oral Contraceptive Treatment. Acta Obstetricia et Gynecologica Scandinavica 51:4, pages 315-317.
Read now

Articles from other publishers (86)

Wolfgang Schramm, Rainer Seitz & Lutz Gürtler. (2020) COVID‐19‐associated coagulopathy—Hypothesis: Are children protected due to enhanced thrombin inhibition by higher α2‐Macroglobulin macroglobulin (α2‐M)?. Journal of Thrombosis and Haemostasis 18:9, pages 2416-2418.
Crossref
J.S. Ungerstedt, J. Antovic, M. Blombäck, K. Bremme & H. Johnsson. (2004) Antithrombin antigen and activity in patients with acquired antithrombin deficiency—is there a difference?. Journal of Thrombosis and Haemostasis 2:5, pages 838-839.
Crossref
Rodger L Bick. (2003) Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects. Hematology/Oncology Clinics of North America 17:1, pages 9-36.
Crossref
Rodger L. Bick & Harold Kaplan. (1998) SYNDROMES OF THROMBOSIS AND HYPERCOAGULABILITY. Medical Clinics of North America 82:3, pages 409-458.
Crossref
Rodger L. Bick & Harold Kaplan. (2016) Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias. Clinical and Applied Thrombosis/Hemostasis 4:1, pages 25-50.
Crossref
Faizi A. Siddiqi, Jeffrey Tepler & Gary A. Fantini. (1997) Acquired protein S and antithrombin III deficiency caused by nephrotic syndrome: An unusual cause of graft thrombosis. Journal of Vascular Surgery 25:3, pages 576-580.
Crossref
Nina Iverson & Ulrich Abildgaard. (2016) State-of-the-Art Review : Role of Antithrombin and Tissue Factor Pathway Inhibitor in the Control of Thrombosis and Mediation of Heparin Action. Clinical and Applied Thrombosis/Hemostasis 2:1, pages 1-6.
Crossref
Rodger L. Bick & Dorota Ancypa. (1995) Blood Protein Defects Associated with Thrombosis: Laboratory Assessment. Clinics in Laboratory Medicine 15:1, pages 125-164.
Crossref
Rodger L. Bick. (1994) Hypercoagulability and thrombosis. Medical Clinics of North America 78:3, pages 635-665.
Crossref
I.N. Farstad, D.W.T. Nielsen, R. Ruyter & H.C. Godal. (1990) Thrombin activity in pulmonary emboli obtained at autopsy. Thrombosis Research 59:5, pages 879-882.
Crossref
F. Marongiu, M. Conti, G. Mameli, G.G. Sorano, E. Cossu, R. Cirillo & A. Balestrieri. (1990) Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?. Thrombosis Research 58:2, pages 91-99.
Crossref
C.H. Beresford. (1988) Antithrombin III deficiency. Blood Reviews 2:4, pages 239-250.
Crossref
G. Zettlmeissl, H. Karges & U. Eberhard. 1988. Biotechnology in blood transfusion. Biotechnology in blood transfusion 133 137 .
Peter J. Stow & Frederick A. Burrows. (1987) Continuing Medical Education Article Anticoagulants in anaesthesia. Canadian Journal of Anaesthesia 34:6, pages 632-649.
Crossref
Gerd Zettlmeissl, Hermann Ragg & Hermann E. Karges. (1987) Expression of Biologically Active Human Antithrombin III in Chinese Hamster Ovary Cells. Nature Biotechnology 5:7, pages 720-725.
Crossref
Valentin Fuster, Philip C. Adams, Juan J. Badimon & James H. Chesebro. (1987) Platelet-inhibitor drugs' role in coronary artery disease. Progress in Cardiovascular Diseases 29:5, pages 325-346.
Crossref
Jos Vermylen, Marc Verstraete & Valentin Fuster. (1986) Role of platelet activation and fibrin formation in thrombogenesis. Journal of the American College of Cardiology 8:6, pages 2B-9B.
Crossref
J Jesty. (1986) The kinetics of inhibition of alpha-thrombin in human plasma.. Journal of Biological Chemistry 261:22, pages 10313-10318.
Crossref
Mohanathasan Chelladurai & Pankaj Ganguly. (1986) Thrombin-reactive polypeptides of platelets may regulate inhibition of thrombin by antithrombin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 870:2, pages 204-210.
Crossref
Terje R. Andersson, Mette L. Larsenxy, Grete F. Handeland & Ulrich Abildgaard. (2009) Heparin cofactor II activity in plasma: Application of an automated assay method to the study of a normal adult population. Scandinavian Journal of Haematology 36:1, pages 96-102.
Crossref
A Bollen. (1985) Cloning and expression in micro-organisms of the genetic information coding for human plasma proteins. Journal of Biotechnology 2:6, pages 317-336.
Crossref
C C Heuck, U Schiele, D Horn, D Fronda & E Ritz. (1985) The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin.. Journal of Biological Chemistry 260:8, pages 4598-4603.
Crossref
Marjolein Peters, Ed Jansen, Jan W. ten Cate, Laurens H. Kahle, Paul Ockelford & Cees Breederveld. (2008) Neonatal antithrombin III. British Journal of Haematology 58:4, pages 579-587.
Crossref
Jeffrey S. Flier, Lisa H. Underhill, Stanford Wessler & Sanford N. Gitel. (1984) Warfarin. New England Journal of Medicine 311:10, pages 645-652.
Crossref
J. Mandl, B. Tanács, Z. Spolarics, T. Garzó, I. Mucha, Fw. Antoni, R. Machovich & I. Horvath. (1984) Uptake of arachidonic acid, arachidic acid, oleic acid and their incorporation into phospholipids and triacylglycerols of isolated murine hepatocytes. Effect of thrombin-antithrombin III complex. Thrombosis Research 35:4, pages 407-414.
Crossref
J. H. Winter, A. Fenech, B. Bennett & A. S. Douglas. (2008) Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency. British Journal of Haematology 57:3, pages 527-537.
Crossref
ERIK ANKER, ULRICH ABILDGAARD, RAGNAR ANDERSEN, MAGNE FAGERHOL & GUNNAR BJUNE. (2009) Low antithrombin in severe disease: Consumption or decreased synthesis?. Scandinavian Journal of Haematology 31:S39, pages 59-63.
Crossref
Grete Frantzen Handeland, Ulrich Abildgaard & Ansgar O. Aasen. (2009) Simplified Assay for Antithrombin III Activity Using Chromogenic Peptide Substrate. Scandinavian Journal of Haematology 31:5, pages 427-436.
Crossref
MYRA ROSE, CAROL S. WIDEMAN, B.L. EVATT & ELIZABETH HAFF. (1983) A comparison of antithrombin III procedures. Clinical & Laboratory Haematology 5:2, pages 185-195.
Crossref
Bruce M. Rothschild. (1983) The role of antithrombin III in clinical management of pulmonary embolization. The American Journal of Medicine 74:4, pages 529-531.
Crossref
Pál I. Bauer, József Mandl, Raymund MacHovich, Ferenc Antoni, Tamás Garzo & István Horváth. (1982) Specific binding of thrombin-antithrombin III complex to hepatocytes. Thrombosis Research 28:5, pages 595-606.
Crossref
Hugh C. Kim, Ekkehard Kemmann, Robert M. Shelden & Parvin Saidi. (1981) Response of blood coagulation parameters to elevated endogenous 17β-estradiol levels induced by human menopausal gonadotropins. American Journal of Obstetrics and Gynecology 140:7, pages 807-810.
Crossref
E. THALER & K. LECHNER. (1981) Antithrombin III Deficiency and Thromboembolism. Clinics in Haematology 10:2, pages 369-390.
Crossref
P. Andersen, P. Kierulf & H.C. Godal. (1981) The antiheparin effect of α1-acid glycoprotein: Influence on heparin tolerance during the acute phase reaction. Thrombosis Research 22:5-6, pages 593-602.
Crossref
E. Hiller, F. Hegemann & K. Possinger. (1981) Hypercoagulability in acute esophageal variceal bleeding. Thrombosis Research 22:3, pages 243-251.
Crossref
Masao Tanaka & Kanefusa Kato. (1981) Determination of antithrombin III by sandwich enzymeimmunoassay technique. Thrombosis Research 22:1-2, pages 67-74.
Crossref
T.W. Barrowcliffe & C.A. Eggleton. (1981) Studies of anti-Xa activity in human plasma I: Comparison of a fast-acting inhibitor with antithrombin III. Thrombosis Research 21:4-5, pages 399-411.
Crossref
Thomas M Cosgriff & Barbara A Martin. (2005) Low functional and high antigenic antithrombin iii level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis & Rheumatism 24:1, pages 94-96.
Crossref
D S McLellan, J D Devlin, G H Heyse-Moore & A Aronstam. (1980) Comparison of three methods for the estimation of plasma antithrombin.. Journal of Clinical Pathology 33:5, pages 438-444.
Crossref
Shigeko O. Lau, Joy Y. Tkachuck, Duane K. Hasegawa & J. Roger Edson. (1980) Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. The Journal of Pediatrics 96:3, pages 390-392.
Crossref
T. Lebreton de Vonne & H. Mouray. (1980) The role of antithrombin III, α 2 macroglobulin and α 1 antitrypsin in progresive antithrombin activity of human plasma. International Journal of Biochemistry 12:3, pages 479-484.
Crossref
Vivian Chan, T.K. Chan, Vivian Wong, S. C. Tso & D. Todd. (2008) The Determination of Antithrombin III by Radioimmunoassay and its Clinical Application. British Journal of Haematology 41:4, pages 563-572.
Crossref
K.L. Mettinger, D. Nyman, K.G. Kjellin, Å. Sidén & C.E. Söderström. (1979) Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease. Journal of the Neurological Sciences 41:1, pages 31-38.
Crossref
Anna Borsodi & Raymund Machovich. (1979) Inhibition of esterase and amidase activities of α- and β-thrombin in the presence of antithrombin III and heparin. Biochimica et Biophysica Acta (BBA) - Enzymology 566:2, pages 385-389.
Crossref
Tomas Sveger. (1979) Antithrombin III in adolescents. Thrombosis Research 15:5-6, pages 885-888.
Crossref
A.C. de Boer, L.A.M. van Riel & G.J.H. den Ottolander. (1979) Measurement of antithrombin III, α2-macroglobulin and α1-antitrypsin in patients with deep venous thrombosis and pulmonary embolism. Thrombosis Research 15:1-2, pages 17-25.
Crossref
Stanford Wessler & Sanford N. Gitel. (1978) Coagulation for cardiologists. American Heart Journal 96:6, pages 811-823.
Crossref
T.Lebreton De Yonne & H. Mouray. (1978) Human α2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma. Clinica Chimica Acta 90:1, pages 83-85.
Crossref
Robert H. Kauffmann, Jan J. Veltkamp, Nico H. Van Tilburg & Leendert A. Van Es. (1978) Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. The American Journal of Medicine 65:4, pages 607-613.
Crossref
Milka M. Montiel & David L. McGlasson. (1978) Antithrombin III activity in baboons. Primates 19:2, pages 371-378.
Crossref
Lilian Johansson, Ulla Hedner & Inga Marie Nilsson. (2009) Familial Antithrombin III Deficiency as Pathogenesis of Deep Venous Thrombosis. Acta Medica Scandinavica 204:1-6, pages 491-495.
Crossref
I. Danishefsky, A. Zweben & B.L. Slomiany. (1978) Human antithrombin III. Carbohydrate components and associated glycolipid.. Journal of Biological Chemistry 253:1, pages 32-37.
Crossref
J.R O'Brien & M.D Etherington. (1977) EFFECT OF HEPARIN AND WARFARIN ON ANTITHROMBIN III. The Lancet 310:8050, pages 1232.
Crossref
R.A Fisken, O.H.B Gyde, M.S Kundi, D.E Stableforth, KajA Jorgensen & Erik Stoffersen. (1977) VENOUS THROMBOSIS, HEPARIN-INDUCED ANTITHROMBIN m DEFICIENCY, AND FACTOR VIII. The Lancet 310:8050, pages 1231-1232.
Crossref
S N Gitel, S Wessler & V M Medina. (1977) The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.. Circulation Research 41:2, pages 187-191.
Crossref
Shaukat Ali Oraksai & Raymund Machovich. (1977) Inactivation of α- and β-thrombin by heat defibrinated human plasma. Effect of heparin. Thrombosis Research 10:6, pages 813-822.
Crossref
Rodger L. Bick, Mildred L. Dukes, William L. Wilson & Lajos F. Fekete. (1977) Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Thrombosis Research 10:5, pages 721-729.
Crossref
MORRIS NOTELOVITZ. (1977) Coagulation, Oestrogen and the Menopause. Clinics in Obstetrics and Gynaecology 4:1, pages 107-128.
Crossref
ø. Grimmer & M. K. Fagerhol. (2009) IMMUNOELECTROPHORETIC QUANTITATION OF ANTITHROMBIN III:. International Journal of Peptide and Protein Research 9:2, pages 85-90.
Crossref
L-O. Andersson, L. Engman & E. Henningsson. (1977) Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III-thrombin complex. Journal of Immunological Methods 14:3-4, pages 271-281.
Crossref
Angelina Carvalho & Leonard Ellman. (1976) Hereditary antithrombin III deficiency. The American Journal of Medicine 61:2, pages 179-183.
Crossref
Robert L. Newman, Marjorie Sirridge, Margaret Brinkman & Reaner Shannon. (1976) A study of blood coagulation parameters. American Journal of Obstetrics and Gynecology 125:1, pages 108-114.
Crossref
O.R. Ødegård & A.N. Teien. (1976) Antithrombin III, heparin cofactor and antifactor Xa in a clinical material. Thrombosis Research 8:2, pages 173-178.
Crossref
Kotoku Kurachi, Kazuo Fujikawa, Gottfried Schmer & Earl W. Davie. (2002) Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III. Biochemistry 15:2, pages 373-377.
Crossref
L.A. Learned, J.W. Bloom & M.J. Hunter. (1976) The antithrombin activity of α-I-protease inhibitor: The antitrypsin activity of antithrombin III. Thrombosis Research 8:1, pages 99-109.
Crossref
Philip Davies. 1976. Structure and Function of Plasma Proteins. Structure and Function of Plasma Proteins 189 238 .
P. W. Howie, K. Evans, C. D. Forbes & C. R. M. Prentice. (2005) THE EFFECTS OF STILBOESTROL AND QUINESTROL UPON COAGULATION AND FIBRINOLYSIS DURING THE PUERPERIUM. BJOG: An International Journal of Obstetrics & Gynaecology 82:12, pages 968-975.
Crossref
Sanford N Gitel & Stanford Wessler. (1975) Plasma antithrombin III: A quantitative assay of biological activity. Thrombosis Research 7:1, pages 5-16.
Crossref
Janet L. Lane, Prudence Bird & C. R. Rizza. (2008) A New Assay for the Measurement of Total Progressive Antithrombin. British Journal of Haematology 30:1, pages 103-115.
Crossref
K. Bergström & G. Lahnborg. (1975) The effect of major surgery, low doses of heparin and thromboembolism on plasma antithrombin. Comparison of immediate thrombin inhibiting capacity and the antithrombin III content. Thrombosis Research 6:3, pages 223-233.
Crossref
Howard L. Bleich, Emily S. Boro & Robert D. Rosenberg. (1975) Actions and Interactions of Antithrombin and Heparin. New England Journal of Medicine 292:3, pages 146-151.
Crossref
Paul S. Damus & Garn A. Wallace. (1975) Immunologic measurement of antithrombin III-heparin cofactor and α2macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy. Thrombosis Research 6:1, pages 27-38.
Crossref
Margareta Blombäck, Birger Blombäck, Per Olsson & Lars Svendsen. (1974) The assay of antithrombin using a synthetic chromogenic substrate for thrombin. Thrombosis Research 5:5, pages 621-632.
Crossref
Maggie Miller-Andersson, Håkan Borg & Lars-Olov Andersson. (1974) Purification of antithrombin III by affinity chromatography. Thrombosis Research 5:4, pages 439-452.
Crossref
G. WEISSBACH, M. DOMULA, H. LENK & P. SCHNEIDER. (2008) THE PROGRESSIVE ANTITHROMBIN ACTIVITY AND ITS RELATIONS TO OTHER FACTORS OF THE COAGULATION SYSTEM IN NEWBORNS. Acta Paediatrica 63:4, pages 555-561.
Crossref
BJöRN BJARKE, PETER HERIN & MARGARETA BLOMBåCK. (2008) NEONATAL AORTIC THROMBOSIS: A Possible Clinical Manifestation of Cangenital Antithrombin III Deficiency. Acta Paediatrica 63:2, pages 297-301.
Crossref
H. G. Schwick, H. Trobisch & N. Heimburger. (1974) Importanza e limiti delle tecniche immunologiche nella diagnostica delle coagulopatie. La Ricerca in Clinica e in Laboratorio 4:1-4, pages 617-637.
Crossref
Panos Gavrilis, Robert G. Lerner & Robert Goldstein. (1974) Plasma factor Xa-inhibitory activity in alcoholic liver disease and the effect of heparin. Thrombosis Research 4:2, pages 335-343.
Crossref
Ulla Hedner & Inga Marie Nilsson. (1973) Antithrombin III in a clinical material. Thrombosis Research 3:6, pages 631-641.
Crossref
R. Aschauer, F. Holzknecht & S. Platzer. (1973) Endogene Fibrinolyseinhibitoren bei LebercirrhosenEndogenous inhibitors of fibrinolytic activity in liver cirrhosis. Klinische Wochenschrift 51:23, pages 1170-1172.
Crossref
P. W. Howie, C. R. M. Prentice & G. P. McNicol. (2008) A Method of Antithrombin Estimation using Plasma Defibrinated with Ancrod. British Journal of Haematology 25:1, pages 101-110.
Crossref
N. Stathakis, A.G. Papayannis & C.D. Gardikas. (1973) POSTOPERATIVE ANTITHROMBIN-III CONCENTRATION. The Lancet 301:7800, pages 430.
Crossref
Olav Refvem, Magne K. Fagerhol & Ulrich Abildgaard. (2009) CHANGES IN ANTITHROMBIN III LEVELS FOLLOWING CESSATION OF ANTICOAGULANT THERAPY. Acta Medica Scandinavica 193:1-6, pages 307-309.
Crossref
NATHANIEL F. RODMAN. 1973. The Inflammatory Process. The Inflammatory Process 363 392 .
Richard E. Behrman, Makram W. El-Bardeesy, A. Myron Johnson & Lesley S. Bissett. (1972) Serum proteinase inhibitors in infants with hyaline membrane disease. The Journal of Pediatrics 81:3, pages 579-587.
Crossref
Ewa Marciniak & Sumiko Tsukamura. (2008) Two Progressive Inhibitors of Factor Xa in Human Blood. British Journal of Haematology 22:3, pages 341-351.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.